Mounjaro KwikPen
  1. Home
  2. Mounjaro
  3. Mounjaro KwikPen

Mounjaro KwikPen

Mounjaro KwikPen is a prescription dual GIP and GLP-1 receptor agonist prefilled multi-dose injection pen used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is designed for convenient once-weekly subcutaneous administration with precise dose delivery. The ergonomic KwikPen provides reliable, accurate, and user-friendly medication administration.

BUY NOW

Category

Mounjaro KwikPen contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The multi-dose prefilled injection pen is engineered for precise subcutaneous administration and is available in multiple dosage strengths to support individualized treatment according to the prescribed dose-escalation schedule. Manufactured under stringent pharmaceutical quality standards, the sterile KwikPen delivers dependable clinical performance with consistent once-weekly dosing. Mounjaro KwikPen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro KwikPen
Active Ingredient Tirzepatide
Dosage Form Sterile Multi-Dose Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly (As Prescribed)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro KwikPen, Tirzepatide KwikPen, Mounjaro Injection Pen, Multi-Dose Tirzepatide Pen, Weekly Tirzepatide Pen, GIP GLP-1 Injection Pen, Tirzepatide Prefilled Pen